Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · Real-Time Price · USD
36.36
-0.26 (-0.71%)
At close: Sep 4, 2026, 4:00 PM EDT
37.19
+0.83 (2.28%)
After-hours: Sep 4, 2026, 7:59 PM EDT
Teva Pharmaceutical Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Teva Pharmaceutical stock has a consensus rating of "Buy" and an average price target of $41.6. The average 1-year stock price forecast is 14.41% higher than the current stock price, while the lowest is $33 (-9.24%) and the highest is $50 (+37.51%).
Price Target: $41.6 (+14.41%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Teva Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 7 | 7 | 7 |
| Buy | 4 | 4 | 5 | 5 | 5 | 4 |
| Hold | 1 | 1 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Buy Maintains $42 → $48 | Buy | Maintains | $42 → $48 | +32.01% | Sep 4, 2026 |
| Jefferies | Jefferies | Buy Maintains $40 | Buy | Maintains | $40 | +10.01% | Sep 3, 2026 |
| Scotiabank | Scotiabank | Buy Maintains $40 | Buy | Maintains | $40 | +10.01% | Sep 3, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $50 | Buy | Maintains | $50 | +37.51% | Sep 3, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $41 → $43 | Buy | Reiterates | $41 → $43 | +18.26% | Sep 3, 2026 |
Financial Forecast
Revenue This Year
16.58B
from 17.26B
Decreased by -3.92%
Revenue Next Year
17.30B
from 16.58B
Increased by 4.36%
EPS This Year
n/a
EPS Next Year
n/a